Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Saturday. The firm set a “hold” rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Stock Up 0.6 %

MLSS stock opened at $0.93 on Friday. Milestone Scientific has a twelve month low of $0.54 and a twelve month high of $1.39. The stock’s 50 day moving average is $1.13 and its 200-day moving average is $0.96. The firm has a market capitalization of $72.07 million, a PE ratio of -13.22 and a beta of 1.41.

Institutional Trading of Milestone Scientific

Several hedge funds and other institutional investors have recently made changes to their positions in MLSS. Y Intercept Hong Kong Ltd purchased a new stake in Milestone Scientific in the 3rd quarter worth $48,000. World Investment Advisors LLC purchased a new position in shares of Milestone Scientific during the third quarter valued at about $91,000. Renaissance Technologies LLC lifted its holdings in shares of Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock valued at $121,000 after acquiring an additional 53,198 shares during the last quarter. Carnegie Investment Counsel lifted its holdings in shares of Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after acquiring an additional 27,412 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares during the last quarter. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.